Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5265 USD | -5.27% | +0.80% | -3.09% |
22/03 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
14/03 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.09% | 109M | |
+9.15% | 106B | |
-1.08% | 104B | |
+7.42% | 23.25B | |
-11.55% | 22.5B | |
-7.22% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Sangamo Therapeutics : Wells Fargo Adjusts Price Target on Sangamo Therapeutics to $29 From $36, Maintains Overweight Rating